tradingkey.logo
tradingkey.logo
Search

Oxford Biotherapeutics Trategic Collaboration With Bristol Myers Squibb To Discover And Develop Next-Generation T-Cell Engagers For Solid Tumours

ReutersApr 9, 2026 11:16 AM
facebooktwitterlinkedin

Bristol-Myers Squibb Co BMY.N:

  • OXFORD BIOTHERAPEUTICS: TRATEGIC COLLABORATION WITH BRISTOL MYERS SQUIBB TO DISCOVER AND DEVELOP NEXT-GENERATION T-CELL ENGAGERS FOR SOLID TUMOURS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI